Particle.news

Download on the App Store

EU Court to Rule on Transparency in von der Leyen's Pfizer Texts Case

The decision could redefine what counts as an official document under EU transparency rules but will not compel the release of the messages.

FILE - Syringes with the Pfizer vaccine against COVID-19 disease are ready at a new vaccination center in Paris, Thursday, May 6, 2021. (AP Photo/Michel Euler, File)
Albert Bourla, Chairman and CEO of Pfizer attends the 55th annual World Economic Forum (WEF) meeting in Davos, Switzerland, January 23, 2025. REUTERS/Yves Herman
Pfizer logo is seen in this illustration taken, May 1, 2022. REUTERS/Dado Ruvic/Illustration
FILE - A Belgian Army medic brings lunch to a patient with COVID-19 at the St. Michiel Hospital in Brussels, Tuesday, Nov. 24, 2020. (AP Photo/Virginia Mayo, File)

Overview

  • The Court of Justice of the European Union is set to decide whether the European Commission breached transparency laws by not archiving or releasing text messages between Ursula von der Leyen and Pfizer’s CEO during Covid-19 vaccine negotiations.
  • The Commission argued the texts were not archived because they were not deemed 'substantive,' a claim central to the legal challenge brought by The New York Times in 2023.
  • The EU Ombudsman previously labeled the Commission’s handling of the records request as 'maladministration,' stating the texts should have been subject to transparency rules.
  • The ruling will not force the disclosure of the messages but may clarify whether such communications qualify as official documents under EU law.
  • Critics argue the case highlights institutional blind spots in EU governance, while defenders of von der Leyen emphasize the urgency of securing vaccines during a global crisis.